FRSC CONFIRMS FATAL CRASH THAT KILLED 12 VICTIMS AT GADA BIYU ALONG YANGOJI–ABUJA CORRIDOR. (PHOTO).

Image
 FRSC CONFIRMS FATAL CRASH THAT KILLED 12 VICTIMS AT GADA BIYU ALONG YANGOJI–ABUJA CORRIDOR The Federal Road Safety Corps (FRSC), has confirmed a fatal multiple vehicle road traffic crash that claimed twelve lives at about 1145hrs on Sunday, 11 January 2026, at Gada Biyu, along the Yangoji–Abuja (YGJ–ABJ) corridor. According to a statement signed by the Corps Public Education Officer, Segun Ogungbemide, The crash involved four vehicles: one commercial trailer conveying coal, one commercial bus, and two commercial cars.  Preliminary investigations revealed that the incident could have been caused by speed violation and dangerous driving which led to loss of control. Further information gathered indicated that the truck driver was driving at an excessive speed beyond the legally prescribed limit for the corridor, lost control, and crashed into already parked vehicles, triggering the fatal collision. Out of 18 persons involved in the crash, Five victims died instantly at the scen...

ASTRA-ZENECA FINDS NO EVIDENCE OF INCREASED BLOOD CLOTH RISK FROM VACCINE.{PHOTO}.

 


(Reuters) - AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.

The review covered more than 17 million people vaccinated in the European Union and United Kingdom.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.

Authorities in Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.

Ireland on Sunday temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution”.

The drugmaker said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern.

There are also no confirmed issues related to quality of any of its COVID-19 vaccine batches used across Europe and rest of the world, the company said.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

TINUBU ANNOUNCES ARRIVAL OF 4 U.S ATTACK HELICOPTERS. (PHOTO).